Beyond weight loss, semaglutide also contributes to improved metabolic health, offering advantageous impacts on blood pressure, cholesterol, and glucose levelsoverall supporting healthier life outcomes
A physician may consider tirzepatide for patients who need medical support for obesity, overweight with weight-related health concerns, insulin resistance, blood sugar concerns, appetite control, or metabolic risk
Importantly, tirzepatide may influence fat distribution, particularly by reducing visceral and cervical adiposity, which are closely associated with upper airway obstruction in OSAS
How are PT-141 injections administered